Celltrion’s CT-P59 (regdanvimab) Receives CHMP’s Positive Opinion for the Treatment of COVID-19
Shots: The EMA’s CHMP has issued a positive opinion recommending the marketing authorization for regdanvimab (CT-P59) in adults with COVID-19 who do not require supplemental […]